Matching Items (4)
Filtering by

Clear all filters

136492-Thumbnail Image.png

Instagram and Adoption Rates: The Impact of Proactive Social Media on Adoption Rates at the Arizona Animal Welfare League & SPCA

Description
This thesis explores how we can harness new technology to improve our relationship with companion animals and promote shelter animal welfare. The study looked into using the photo-sharing application Instagram to increase adoption rates at the Arizona Animal Welfare League & SPCA. An Instagram page was created and managed for…

This thesis explores how we can harness new technology to improve our relationship with companion animals and promote shelter animal welfare. The study looked into using the photo-sharing application Instagram to increase adoption rates at the Arizona Animal Welfare League & SPCA. An Instagram page was created and managed for the shelter, and data was collected regarding the impact the page had on adoption rates. The results were mixed, but overall it was determined that the Instagram page has unique value for the shelter.
ContributorsBautista-Hobin, Elena Maria (Author) / Minteer, Ben (Thesis director) / Ellison, Karin (Committee member) / Morefield, Michael (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor)
Created2015-05
136378-Thumbnail Image.png

The Market For Bodies: Investigating the Landscape of Nontransplant Anatomical Donation Organizations

Description
While there is extensive information available about organizations that receive donated organs for transplant, much less is known about those that accept tissue and whole bodies for medical education and research. Throughout the United States, nontransplant anatomical donation organizations exist within an ambiguous sector of the donation industry, unencumbered by…

While there is extensive information available about organizations that receive donated organs for transplant, much less is known about those that accept tissue and whole bodies for medical education and research. Throughout the United States, nontransplant anatomical donation organizations exist within an ambiguous sector of the donation industry, unencumbered by federal regulations. Although these companies adhere to the Uniform Anatomical Gift Act, the lack of a single entity responsible for overseeing their operations has led to public skepticism and animosity among competing businesses. Legislation has the potential to legitimize the industry. For it to be successful, however, the intricacies of a complex market that deals directly with the movement of human remains and intangible issues of human integrity and morality, must be thoroughly understood.
ContributorsGlynn, Emily Sanders (Author) / Brian, Jennifer (Thesis director) / Fisher, Rebecca (Committee member) / Barrett, The Honors College (Contributor) / School of Nutrition and Health Promotion (Contributor) / Department of English (Contributor)
Created2015-05
137336-Thumbnail Image.png

Perception of Phase 1 Cancer Clinical Trials

Description
Mr. Green has stage 4 prostate cancer which has spread to the bones and liver and has become resistant to radiation and standard chemotherapy treatment. After 3 rounds of chemotherapy, his primary oncologist recommends that he participate in a clinical trial. He went to Dr. Red at the Saguaro Clinic…

Mr. Green has stage 4 prostate cancer which has spread to the bones and liver and has become resistant to radiation and standard chemotherapy treatment. After 3 rounds of chemotherapy, his primary oncologist recommends that he participate in a clinical trial. He went to Dr. Red at the Saguaro Clinic after reading on the internet about a new Phase 1 clinical trial that the clinic is hosting, which is designed to target a specific receptor called AB-111 that may be present in malignant prostate, cervical, ovarian, and breast cells. After signing consent and completing the blood screens in the morning at the clinic, Mr. Green is told his liver enzymes are too high and the ranges specified in the protocol prohibit him from enrolling. Mr. Green is noticeably affected and distressed at this news, and Dr. Red recommends end-of-life care. Behind the scenes, this event is noted on official medical documents and trial study rosters as a "screen fail." This narrative, while fictional, is realistic because similar events occur in cancer clinical trial sites on a regular basis. I look at the inner "world" and mental journey of possible clinical trial candidates as they seek out information about clinical trials and gain understanding of their function \u2014 specifically in the context of Phase 1 cancer clinical trials. To whom is the language of the term "screen failure" useful? How does excluding individuals from clinical trials protect their health and does the integrity of the trial data supersede the person's curative goals? What is the message that cancer patients (potential research subjects) receive regarding clinical trials from sources outside their oncologists?
ContributorsMcKane, Alexandra (Author) / Maienschein, Jane (Thesis director) / Ellison, Karin (Committee member) / Foy, Joseph (Committee member) / Barrett, The Honors College (Contributor)
Created2013-12

An Analysis of the Ethical and Functional Perspectives Regarding Sex Inclusive Research

Description

The basic goal of preclinical animal research is to improve understanding of human disease and treatment. Mandates for sex-inclusive research – both in preclinical animal work and in human clinical trials – have prompted discussions about the ethics and functionality of sex-inclusive research. Authors of peer review research articles and…

The basic goal of preclinical animal research is to improve understanding of human disease and treatment. Mandates for sex-inclusive research – both in preclinical animal work and in human clinical trials – have prompted discussions about the ethics and functionality of sex-inclusive research. Authors of peer review research articles and opinion pieces have varying opinions regarding sex-inclusive preclinical animals research. The arguments that support sex inclusion in animal research include: a) sex inclusive research in the preclinical animal model stage saves money further down the road in research, b) new understanding in hormonal variation in both male and female mice undercuts a notion that male mice are simpler research subjects, and c) sex-inclusive research is needed for improved treatment and diagnosis for male and female humans down the road. Arguments against inclusive research include: a) increased research cost and time, and b) sex-inclusive preclinical animal research is not useful, and may be harmful, to the development of personalized medicine. Weighing the different arguments present in the conversation regarding sex inclusive research, sex inclusive research is clearly important and necessary moving forward for cost efficiency, scientific discovery, and movement towards precision medicine.
ContributorsFagan, Erin (Author) / Ellison, Karin (Thesis director) / Smith, Lindsay (Committee member) / Barrett, The Honors College (Contributor) / School of Human Evolution & Social Change (Contributor) / School of Life Sciences (Contributor)
Created2023-05